Accord Healthcare to expand presence on Romanian oncology market

Newsroom 26/01/2017 | 16:05

The Romanian division of Accord Healthcare, part of the Indian Intas Group, plans to expand expand its products portfolio and its position consolidation on oncology market from Romania.

“Currently, Accord registers very good results at European level, where we own for all the molecules that we sell a market share of around 30 percent. Having these strong premises, we can say that our objective is to reach similar figures in Romania in the next 3-5 years,” said Daniel Bran, general director of Accord Healthcare in Romania.

Accord Healthcare, which is specialized in the oncology injectables products, expects to get a similar market share in Romania as in the other European countries.

The company, owns a factory in Haverhill, Cambridge in UK and a new production unit in Fawdon, Tyne and Wear.

On January 9, Intas Pharmaceuticals finished the acquisition of the generic business Actavis from UK and Ireland from Teva Pharmaceutical Industries Ltd, worth GBP 603 million, which resulted in the strengthening of its presence on the retail market from UK. Also, before this acquisition the company invested in the reopening of a unit in Newcastle.